Literature DB >> 850070

The reactions of antibodies to paragloboside (lacto-N-neotetraosyl ceramide) with human erythrocytes and lymphocytes.

G A Schwarting, D M Marcus.   

Abstract

Paragloboside (lacto-N-neotetraosyl ceramide) is a biosynthetic precursor of the ABH and P1 blood group glycosphingolipids and of one class of gangliosides. This study concerns the specificity of rabbit anti-paragloboside antibodies, andtheir reactions with human erythrocytes and lymphocytes. Lacto-N-neotetraose was approximately 10 times as effective as lacto-N-tetraose in inhibiting complement fixation by purified IgG antibodies to paragloboside. The purified antibodies cross-reacted weakly with lactosyl ceramide, asialo GM1, and lacto-N-neotetraosyl polylysine. The purified IgG and IgM antibodies exhibited weak hemagglutinating activity which was enhanced by treatment of erythrocytes with papain or neuraminidase. In contrast to a macroglobulin described by Tsai et al. (J. Immunol. 117:717, 1976), which also binds paragloboside and lacto-N-neotetraose, anti-paragloboside antibodies reacted equally well with normal adult, O1, and umbilical cord erythrocytes. The IgG antibodies to paragloboside reacted with about 60% of B lymphocytes of peripheral blood and 5 to 10% of T cells. The relationship between antibodies to paragloboside and other lectins and antibodies directed against beta-galactosyl groups, including anti-T (Thomsen-Friedenreich) antibodies, is discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850070

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

1.  The cholesterol-dependent cytolysins pneumolysin and streptolysin O require binding to red blood cell glycans for hemolytic activity.

Authors:  Lucy K Shewell; Richard M Harvey; Melanie A Higgins; Christopher J Day; Lauren E Hartley-Tassell; Austen Y Chen; Christine M Gillen; David B A James; Francis Alonzo; Victor J Torres; Mark J Walker; Adrienne W Paton; James C Paton; Michael P Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

2.  Blood-group-Ii-active gangliosides of human erythrocyte membranes.

Authors:  T Feizi; R A Childs; S I Hakomori; M E Powell
Journal:  Biochem J       Date:  1978-07-01       Impact factor: 3.857

3.  The exploitation of human glycans by Group A Streptococcus.

Authors:  Anuk D Indraratna; Arun Everest-Dass; Danielle Skropeta; Martina Sanderson-Smith
Journal:  FEMS Microbiol Rev       Date:  2022-05-06       Impact factor: 15.177

4.  My career as an immunoglycobiologist.

Authors:  Donald M Marcus
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2013       Impact factor: 3.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.